|1 Table of Contents 3
|1.1 List of Tables 7
|1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Aesthetic Devices Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 12
3 Aesthetic Devices Market, United States 17
3.1 Aesthetic Devices Market, United States, Revenue ($m), 2018-2033 17
3.2 Aesthetic Devices Market, United States, Revenue Mix ($m), 2023 19
3.3 Aesthetic Devices Market, United States, Category Contribution by Revenue ($m), 2023 20
3.4 Aesthetic Devices Market, United States, Revenue ($m), 2018-2033 22
3.5 Aesthetic Devices Market, United States, Volume (Units), 2018-2033 24
3.6 Aesthetic Devices Market, United States, Volume (Units), 2018-2033 26
3.7 Aesthetic Devices Market, United States, Company Share by Revenue ($m), 2023 29
4 Aesthetic Implants Market, United States 31
4.1 Aesthetic Implants Market, United States, Revenue Mix ($m), 2023 31
4.2 Aesthetic Implants Market, United States, Segment Contribution (%), 2023 32
4.3 Aesthetic Implants Market, United States, Revenue ($m), 2018-2033 34
4.3.1 Breast Implants Market, United States, Revenue ($m), by Segment, 2018-2033 36
4.3.2 Face Implants Market, United States, Revenue ($m), by Segment, 2018-2033 38
4.3.3 Penile Implants Market, United States, Revenue ($m), by Segment, 2018-2033 40
4.4 Aesthetic Implants Market, United States, Volume (Units), 2018-2033 42
4.4.1 Breast Implants Market, United States, Volume (Units), by Segment, 2018-2033 44
4.4.2 Face Implants Market, United States, Volume (Units), by Segment, 2018-2033 47
4.4.3 Penile Implants Market, United States, Volume (Units), by Segment, 2018-2033 49
4.5 Aesthetic Implants Market, United States, Average Price ($), 2018-2033 51
4.6 Aesthetic Implants Market, United States, Distribution Share by Revenue ($m), 2018-2033 53
4.7 Aesthetic Implants Market, United States, Company Share by Revenue ($m), 2023 54
5 Aesthetic Injectables Market, United States 56
5.1 Aesthetic Injectables Market, United States, Revenue Mix ($m), 2023 56
5.2 Aesthetic Injectables Market, United States, Segment Contribution (%), 2023 57
5.3 Aesthetic Injectables Market, United States, Revenue ($m), 2018-2033 59
5.3.1 Hyaluronic Acid Fillers Market, United States, Revenue ($m), by Segment, 2018-2033 61
5.3.2 Non Hyaluronic Acid Fillers Market, United States, Revenue ($m), by Segment, 2018-2033 63
5.4 Aesthetic Injectables Market, United States, Volume (Units), 2018-2033 65
5.4.1 Hyaluronic Acid Fillers Market, United States, Volume (Units), by Segment, 2018-2033 67
5.4.2 Non Hyaluronic Acid Fillers Market, United States, Volume (Units), by Segment, 2018-2033 69
5.5 Aesthetic Injectables Market, United States, Average Price ($), 2018-2033 71
5.6 Aesthetic Injectables Market, United States, Distribution Share by Revenue ($m), 2018-2033 72
5.7 Aesthetic Injectables Market, United States, Company Share by Revenue ($m), 2023 73
6 Body Contouring Devices Market, United States 75
6.1 Body Contouring Devices Market, United States, Revenue Mix ($m), 2023 75
6.2 Body Contouring Devices Market, United States, Segment Contribution (%), 2023 76
6.3 Body Contouring Devices Market, United States, Revenue ($m), 2018-2033 78
6.3.1 Minimally Invasive Body Contouring Devices Market, United States, Revenue ($m), by Segment, 2018-2033 80
6.3.2 Non Invasive Body Contouring Devices Market, United States, Revenue ($m), by Segment, 2018-2033 82
6.4 Body Contouring Devices Market, United States, Volume (Units), 2018-2033 84
6.4.1 Minimally Invasive Body Contouring Devices Market, United States, Volume (Units), by Segment, 2018-2033 86
6.4.2 Non Invasive Body Contouring Devices Market, United States, Volume (Units), by Segment, 2018-2033 88
6.5 Body Contouring Devices Market, United States, Average Price ($), 2018-2033 90
6.6 Body Contouring Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 92
6.7 Body Contouring Devices Market, United States, Company Share by Revenue ($m), 2023 93
7 Laser Resurfacing Devices Market, United States 95
7.1 Laser Resurfacing Devices Market, United States, Revenue Mix ($m), 2023 95
7.2 Laser Resurfacing Devices Market, United States, Segment Contribution (%), 2023 96
7.3 Laser Resurfacing Devices Market, United States, Revenue ($m), 2018-2033 98
7.3.1 Multi Technology Combination Laser Devices Market, United States, Revenue ($m), by Segment, 2018-2033 100
7.3.2 Single Technology Laser Devices Market, United States, Revenue ($m), by Segment, 2018-2033 102
7.4 Laser Resurfacing Devices Market, United States, Volume (Units), 2018-2033 104
7.4.1 Multi Technology Combination Laser Devices Market, United States, Volume (Units), by Segment, 2018-2033 106
7.4.2 Single Technology Laser Devices Market, United States, Volume (Units), by Segment, 2018-2033 108
7.5 Laser Resurfacing Devices Market, United States, Average Price ($), 2018-2033 110
7.6 Laser Resurfacing Devices Market, United States, Distribution Share by Revenue ($m), 2018-2033 112
7.7 Laser Resurfacing Devices Market, United States, Company Share by Revenue ($m), 2023 113
8 Overview of Key Companies in United States, Aesthetic Devices Market 115
8.1 Allergan Aesthetics 115
8.1.1 Company Overview 115
8.2 Galderma SA 115
8.2.1 Company Overview 115
8.3 Mentor Worldwide LLC 115
8.3.1 Company Overview 115
8.4 Candela Corp 115
8.4.1 Company Overview 115
8.5 Boston Scientific Corp 116
8.5.1 Company Overview 116
8.6 Stryker Corp 116
8.6.1 Company Overview 116
8.7 Sientra Inc 116
8.7.1 Company Overview 116
8.8 Merz Pharma GmbH & Co KgaA 116
8.8.1 Company Overview 116
9 Aesthetic Devices Market Pipeline Products 117
10 Financial Deals Landscape 118
10.1 Acquisition 118
10.1.1 CurrentBody Acquires Tria Beauty 118
10.1.2 Sonendo to Acquire Biolase for USD14 Million 119
10.1.3 Valsoft Acquires Anju Software 121
10.1.4 Crown Laboratories Acquires Revance Therapeutics for USD924 Million 122
10.1.5 Exeltis USA Acquires Agile Therapeutics for Approximately USD45 Million 124
10.1.6 Tiger Aesthetics Medical Acquires Sientra for USD44.69 Million 126
10.1.7 NetBrands Plans to Acquire Elevare Skincare, Omm Imports, Market Innovations (Zero Gravity Skin) 128
10.2 Asset Transactions 129
10.2.1 Tiger Aesthetics Acquires Select Assets from Suneva Medical 129
10.2.2 Crown Aesthetics Acquires Assets and Technology from Healeon 130
10.2.3 Elekta to Acquire Pinnacle Treatment Planning System (TPS) Portfolio from Philips Healthcare 131
10.3 Debt Offerings 132
10.3.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of
3.518% Notes Due 2032 132
11 Recent Developments 133
11.1 Corporate Communications 133
11.1.1 Jan 13, 2025: SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales 133
11.1.2 Dec 17, 2024: BeautyHealth Appoints Stephen J. Fanning to Board of Directors 133
11.1.3 Oct 18, 2024: American Shared Hospital Services Announces Key Management Appointments 133
11.1.4 Jun 11, 2024: Hamilton Thorne Announces Voting Results of 2024 Annual Meeting 134
11.2 Financial Announcements 135
11.2.1 Mar 19, 2025: AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event 135
11.2.2 Jan 21, 2025: Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s Guidance 135
11.2.3 Jan 13, 2025: SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) 136
11.2.4 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results 136
11.2.5 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event 138
11.2.6 Nov 08, 2024: SANUWAVE Posts Financial Results for Three Months Ended September 30, 2024 138
11.2.7 Nov 08, 2024: BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024 139
11.2.8 Nov 04, 2024: SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results 139
11.2.9 Oct 17, 2024: Anika Announces Third Quarter 2024 Results Conference Call Date 139
11.2.10 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results 139
11.2.11 Oct 03, 2024: AngioDynamics Announces Fiscal Year 2025 Q1 Results 140
11.2.12 Oct 01, 2024: AbbVie to Host Third-Quarter 2024 Earnings Conference Call 141
11.2.13 Sep 25, 2024: Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024 141
11.2.14 Aug 13, 2024: Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results 143
11.2.15 Aug 07, 2024: Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024 144
11.2.16 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results 144
11.2.17 Aug 01, 2024: InMode Announces Q2 2024 Results 145
11.2.18 Jul 31, 2024: Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance 147
11.2.19 Jul 02, 2024: AbbVie to Host Second-Quarter 2024 Earnings Conference Call 148
11.3 Government and Public Interest 148
11.3.1 Mar 10, 2025: AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference 148
11.3.2 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event 148
11.3.3 Sep 04, 2024: InMode to Present at 2024 Baird Global Healthcare Conference 148
11.3.4 Jul 29, 2024: AngioDynamics to Participate in Upcoming Investor Conferences 149
11.3.5 Jul 10, 2024: EMA Recommends Granting a Marketing Authorisation for Erdafitinib 149
11.4 Legal And Regulatory 150
11.4.1 Mar 28, 2025: Corbus Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity 150
11.4.2 Mar 18, 2025: Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance 150
11.4.3 Feb 25, 2025: Actuate Announces Completion of Enrollment in a Phase 2 Trial of Elraglusib in Combination With Folfirinox and Losartan With Pancreatic Cancer 151
11.4.4 Aug 26, 2024: Strata Skin Sciences Files Complaint Against Laseroptek, Monarch Laser Services, And The Pinnacle Health Group 152
11.4.5 Jun 10, 2024: Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product 153
11.4.6 May 17, 2024: Morgan Scientific and ZEPHYRx Have Partnered to Advance Respiratory Care 154
11.5 Other Significant Developments 154
11.5.1 Mar 05, 2025: Young Pharmaceuticals Now Accepts Cryptocurrency for Private-Label Skincare and Aesthetic Technologies 154
11.5.2 Feb 27, 2025: Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East 155
11.5.3 Feb 18, 2025: Verve Medical Cosmetics Celebrates 25th Anniversary by Offering Tips For Choosing The Right Injectables Provider 155
11.5.4 Feb 12, 2025: Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training 156
11.5.5 Jan 29, 2025: Allergan Aesthetics Launches New AA Signature Program at Imcas 2025 To Redefine Patient-Centric, Multimodal Treatment Plans 157
11.5.6 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results 157
11.5.7 Jan 07, 2025: InkSpace Imaging Receives Additional 510(K) Clearance For Imaging Body Array 159
11.5.8 Dec 17, 2024: RTI Surgical Transforms into Evergen, a Leading Cdmo in Regenerative Medicine 160
11.5.9 Dec 17, 2024: Aeroflow Breastpumps Awarded Contract to Provide Breast Pumps to Medicaid Members in Montana 160
11.5.10 Aug 05, 2024: Create New Materials Using Precision Multi-ion Implantation 160
11.5.11 Jul 31, 2024: Cutera Announces Exclusive Distribution Agreement With L’Oreal for SkinCeuticals Products in Japan 161
11.5.12 Jul 22, 2024: Revision Skincare to Host Its Annual Business-Building Elite Retreat for Top Aesthetics Practices across the U.S., Showcasing Trailblazing Women Who Make an Impact 161
11.5.13 Jun 28, 2024: Aspen Laser and Theralight Complete Corporate and Warehouse Expansion 162
11.5.14 Jun 27, 2024: Introducing Alle Payment Plans, Powered by Cherry 162
11.5.15 May 15, 2024: BioRestorative Therapies Announces Commercial Agreement with Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market 163
11.5.16 Apr 30, 2024: Biorestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology 164
11.6 Product News 164
11.6.1 Mar 24, 2025: Merz Aesthetics Sponsors Symposium Highlighting Market Trends With a Portfolio Approach at the 2025 Aesthetic and Anti-aging Medicine World Congress (AMWC) 164
11.6.2 Mar 03, 2025: UTSW Researchers Use Focused Ultrasound to Identify Stroke Biomarkers 165
11.6.3 Feb 27, 2025: Dr. Wilson Dumornay Now Offering Thyroid Radiofrequency Ablation (RFA) at Broward Ent & Aesthetics 166
11.6.4 Jan 28, 2025: Early Detection Is a Game Changer: Novartis Makes Bold Play to Prioritize Breast Health and Inspire a New Wave of Breast Cancer Screenings 166
11.6.5 Jan 20, 2025: SBC Medical Announces Launch of Proprietary Translation App 168
11.6.6 Jan 16, 2025: Hugel Vows to Become Global Leader at J.P. Morgan Healthcare Conference 169
11.6.7 Dec 05, 2024: Platinum Dermatology Partners Announces Launch of Aesthetics Research Committee 169
11.6.8 Sep 25, 2024: Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events 170
11.6.9 Sep 10, 2024: “Dermatologic Surgery” Journal Publishes Special Issue on Neuromodulators 170
11.6.10 Jul 18, 2024: NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal 172
11.6.11 Jul 15, 2024: Hyaluronic Acid Lip Fillers Safe for Patients with Systemic Sclerosis 172
11.6.12 May 07, 2024: Turn Biotechnologies Discussed Emerging Therapies at Aesthetic Plastic Surgery Society Meeting 173
11.7 Strategy And Business Planning 173
11.7.1 Mar 06, 2025: Establishment Labs Announces Partnership With Meghan Trainor 173
11.7.2 Feb 24, 2025: Injectco Announces Opening of New Dallas, Texas Location 174
11.7.3 Feb 12, 2025: Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training 174
11.7.4 Nov 07, 2024: POP Recovery Systems Announces Partnership With Symplast 175
11.7.5 Nov 04, 2024: Acclaro Medical Announces Opening of New Headquarters in Munich, Germany 175
11.7.6 Apr 16, 2024: Wingderm Shines Bright in the U.S.A. Continuously Expanding the Local Business Network 176
12 Appendix 177
12.1 Research Methodology 178
12.1.1 Coverage 178
12.1.2 Secondary Research 178
12.1.3 Primary Research 179
12.1.4 Market Modeling and Forecasting 179
12.1.5 Company Share Analysis 181
12.1.6 Distribution Share Analysis 181
12.1.7 Benchmarking 181
12.2 GlobalData Consulting 182
12.3 Contact Us 182
12.4 Disclaimer 182
